Oklahoma Attorney General Mike Hunter plans to appeal a $465 million opioid judgment after the judge refused to extend the abatement funds beyond a year.

The state joins Johnson & Johnson, sole defendant in the case, along with its subsidiary, Janssen Pharmaceuticals, in appealing the Nov. 15 judgment, which followed the first trial in the nation over the opioid crisis. At trial, the state’s lawyers had argued for $17.5 billion paid out over 30 years to fix the opioid crisis in Oklahoma.